title: Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
authors.affiliation: Division of Oncology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: R F
authors.initials: RF
authors.lastname: Raff
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: F
authors.initials: F
authors.lastname: Schuening
authors.forename: B
authors.initials: B
authors.lastname: Sandmaier
authors.forename: H
authors.initials: H
authors.lastname: Shulman
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: T
authors.initials: T
authors.lastname: Graham
mesh_terms: D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D004285:Dogs / Q000276:immunology*; D006084:Graft Rejection; D006649:Histocompatibility Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I; D008212:Lymphocyte Depletion; D011828:Radiation Chimera; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D015395:Histocompatibility Antigens Class I; C039692:histocompatibility antigen DLA